文献速递中医内科中药与中成药合理使用

胃复春胶囊经Toll样受体通路介导HES6与免疫调节治疗慢性萎缩性胃炎

Exploring the effect of Weifuchun capsule on the toll-like receptor pathway mediated HES6 and immune regulation against chronic atrophic gastritis.
PubMed 文献 · J Ethnopharmacol · 2022-11-17

本研究结合LC-MS/MS成分鉴定、网络靶点分析与MNNG-GES-1细胞系及大鼠模型实验,探讨胃复春胶囊治疗慢性萎缩性胃炎的作用机制。研究发现胃复春胶囊通过Toll样受体信号通路抑制炎症因子、调节T细胞与巨噬细胞等免疫细胞及相关基因TLR2和CD14,并抑制HES6表达(P < 0.05)。

要点

  • 胃复春胶囊可能通过Toll样受体通路调节免疫、抑制炎症治疗慢性萎缩性胃炎。
  • 胃复春胶囊可抑制HES6表达(P < 0.05),HES6与胃炎癌变进展相关。
  • 研究为中药网络与系统研究提供了标准范例。

核心结论

  • 胃复春胶囊通过调节免疫反应、抑制炎症治疗慢性萎缩性胃炎,并抑制HES6表达(P < 0.05)。

研究设计与样本

  • 采用LC-MS/MS鉴定胃复春胶囊化合物,并进行系统网络靶点分析。
  • 整合组学数据与算法聚焦Toll样受体信号通路及HES6的免疫调节作用。
  • 实验部分使用MNNG-GES-1细胞系和大鼠模型验证发现。

主要发现

  • 胃复春胶囊抑制炎症细胞因子,调节T细胞和巨噬细胞等免疫细胞。
  • 胃复春胶囊调节TLR2和CD14等相关基因。
  • 胃复春胶囊抑制HES6表达(P < 0.05),HES6是新发现的与胃炎癌变进展相关的生物分子。

关键数值与推荐

  • 胃复春胶囊抑制HES6表达的统计学显著性为P < 0.05。

临床怎么用

  • 为胃复春胶囊治疗慢性萎缩性胃炎提供了免疫调节与抗炎机制的网络与实验依据。
  • 提示Toll样受体通路、TLR2、CD14及HES6可作为后续研究或临床监测的候选分子。

局限性

  • 原文摘要未报告样本量、剂量、阈值等具体实验参数。
  • 机制验证主要基于细胞系和大鼠模型,尚需临床研究进一步确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Weifuchun capsule (WFC) is a traditional Chinese patent medicine for chronic atrophic gastritis (CAG) in clinic. However, the mechanism of action of WFC for CAG still remains unclear due to its complex composition. AIM OF THE STUDY: The study was projected to uncover the mechanism of action of WFC and the corresponding pharmacodynamic substance of WFC against CAG as well as providing a standard example for the research of traditional Chinese medicine (TCM) from the perspective of the network and the system. MATERIALS AND METHODS: We identified the compounds of WFC through LC-MS/MS analysis and performed a systematic network targets analysis for WFC in the treatment of CAG which thoroughly described the mechanism of action of WFC for CAG. Based on analysis integrating omics data and algorithms, we focused on the specific immune regulatory role of WFC in the treatment of CAG, especially on a hub pathway, Toll-like receptor signaling pathway and thus deciphered the role of WFC in immune regulation, anti-inflammation and mediation of HES6. In experiments part, MNNG-GES-1-cell line and rat models were used to validate our findings. RESULTS: In this study, compounds of WFC are identified through LC‒MS/MS and network target analysis is performed to dissect the specific immunoregulatory effect as well as mediation of HES6, a newly discovered biomolecule related to gastritis carcinoma progression, of WFC on CAG through the Toll-like receptor signaling pathway. Based on cell line and rat models, we verify the mechanism of action of WFC for CAG in inhibiting inflammatory cytokines, regulating immune cells like T cells and macrophages, related genes including TLR2 and CD14. It is also validated that WFC inhibits the expression of HES6 (P < 0.05). CONCLUSION: Based on the combination of computational strategy and experiments, our study offers a comprehensive analysis to reveal the role of WFC in regulating immune response, inhibiting inflammation in the treatment of CAG, and provides a standard example for the research of TCM from the perspective of the network and the system.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Wang B, Zhou W, Zhang H, et al. Exploring the effect of Weifuchun capsule on the toll-like receptor pathway mediated HES6 and immune regulation against chronic atrophic gastritis. J Ethnopharmacol. 2022. PMID: 36403744. doi:10.1016/j.jep.2022.115930

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。